Suppr超能文献

皮质类固醇和非甾体抗炎疗法对亚急性甲状腺炎后永久性甲状腺功能减退症的影响。

The Effects of Corticosteroid and Nonsteroid Anti-Inflammatory Therapies on Permanent Hypothyroidism Occurring After the Subacute Thyroiditis.

机构信息

Division of Endocrinology and Metabolism, Department of Internal Medicine, Kartal Dr. Lutfi Kirdar City Hospital, Kartal, Turkey.

出版信息

Endocr Res. 2024 Feb-May;49(3):137-144. doi: 10.1080/07435800.2024.2344719. Epub 2024 Apr 21.

Abstract

OBJECTIVE

Subacute thyroiditis(SAT) is an acute inflammatory, self-limited, and destructive disease of the thyroid gland. Although it is a temporary disease, it has permanent consequences. We aim to investigate the influences of the treatment choice on permanent hypothyroidism occurring after SAT and whether there are predictive factors for the development of permanent hypothyroidism.

METHODS

We retrospectively investigated 57 SAT patients admitted to our tertiary hospital between 2017 and 2019. After excluding 6 patients, demographic, clinical, laboratory, and imaging findings of 36 patients treated with NSAIDs and 15 patients treated with corticosteroids were compared. The median duration of follow-up was 4 (3.5-5.5) years.

RESULTS

Permanent hypothyroidism occurred in 16 patients (31.4%) of 51 patients. It developed at a significantly higher rate in NSAID users (p=0.019). There was no significant difference in the occurrence of transient hypothyroidism and recurrence (p=0.472, p=0.082). The early maximum TSH values were strongly associated with permanent hypothyroidism. The Odds Ratio (OR) value was 2.59 (95% CI = 1.26 - 5.33, p=0.009), Nagelkerke R2 = 0.821. The early maximum TSH level had a predictive value, with an AUC of 0.966 for post-SAT permanent hypothyroidism (p<0.001). The cutoff values for the early maximum TSH were 9.07uIU/ml (81.3% sensitivity, 100% specificity), and 7.05 uIU/ml (87.5% sensitivity, 94.3% specificity).

CONCLUSION

Corticosteroid therapy is significantly effective in preventing permanent hypothyroidism from developing after SAT. The early maximum TSH values are an indicator for the prediction of the development of permanent hypothyroidism.

摘要

目的

亚急性甲状腺炎(SAT)是一种甲状腺的急性炎症、自限性和破坏性疾病。尽管它是一种暂时性疾病,但它会产生永久性的后果。我们旨在研究治疗选择对 SAT 后永久性甲状腺功能减退症发生的影响,以及是否存在永久性甲状腺功能减退症发展的预测因素。

方法

我们回顾性调查了 2017 年至 2019 年期间在我们的三级医院就诊的 57 例 SAT 患者。排除 6 例患者后,比较了 36 例接受 NSAIDs 治疗和 15 例接受皮质类固醇治疗的患者的人口统计学、临床、实验室和影像学发现。中位随访时间为 4(3.5-5.5)年。

结果

51 例患者中有 16 例(31.4%)发生永久性甲状腺功能减退症。在 NSAID 使用者中,永久性甲状腺功能减退症的发生率显著更高(p=0.019)。暂时性甲状腺功能减退症和复发的发生率无显著差异(p=0.472,p=0.082)。早期最大 TSH 值与永久性甲状腺功能减退症密切相关。优势比(OR)值为 2.59(95%置信区间为 1.26-5.33,p=0.009),Nagelkerke R2=0.821。早期最大 TSH 值具有预测价值,用于 SAT 后永久性甲状腺功能减退症的 AUC 为 0.966(p<0.001)。早期最大 TSH 的截断值为 9.07uIU/ml(81.3%的敏感性,100%的特异性)和 7.05 uIU/ml(87.5%的敏感性,94.3%的特异性)。

结论

皮质类固醇治疗对 SAT 后永久性甲状腺功能减退症的发生具有显著的预防作用。早期最大 TSH 值是预测永久性甲状腺功能减退症发展的指标。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验